Drilldown: Medicines
Appearance
Medicines > fda max:
100 mg/d (ED); 20 mg TID (PAH)
& onset
:
Postprandial glucose effect within days; HbA1c by 12 weeks
or
Symptom improvement within 1 week; peak effect at 4-6 weeks 
& onset
:
Postprandial glucose effect within days; HbA1c by 12 weeks
or
Symptom improvement within 1 week; peak effect at 4-6 weeks 
Use the filters below to narrow your results.
There are no results for this report.

